Phase 1 34 trials
Phase 1
NCT04479306 Jun 2020 → Jul 2023 non-small cell lung carcinoma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT04085315 Nov 2019 → Dec 2026 expected lung cancer Collin Blakely
Recruiting
No outcome recorded
Phase 1
NCT02700022 Oct → Nov 2016 Burkitt lymphoma , diffuse large B-cell lymphoma , follicular lymphoma UNC Lineberger Comprehensive Cancer Center
Terminated
No outcome recorded
Phase 1
NCT02812056 Sep 2016 → Sep 2021 digestive system cancer , female reproductive organ cancer , head and neck cancer , male reproductive organ cancer M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1
NCT02719691 May 2016 → Mar 2020 breast cancer University of Colorado, Denver
Completed
No outcome recorded
Phase 1
NCT02780011 Dec 2015 → Sep 2018 non-Hodgkin lymphoma Eric Bernicker, MD
Withdrawn
No outcome recorded
Phase 1
NCT02551055 Oct 2015 → Feb 2017 adenocarcinoma Millennium Pharmaceuticals, Inc.
Terminated
No outcome recorded
Phase 1
NCT02319018 Aug 2015 → Sep 2018 digestive system cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT02367352 Mar 2015 → May 2017 ovarian cancer , small cell lung carcinoma Millennium Pharmaceuticals, Inc.
Terminated
No outcome recorded
Phase 1
NCT02186509 Jan 2015 → Mar 2017 adult anaplastic ependymoma , adult brainstem glioma , adult glioblastoma , adult oligodendroglioma +8 Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 1
NCT02327169 Jan 2015 → Jul 2018 neoplastic disease or syndrome Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT02219789 Dec 2014 → Mar 2016 estrogen-receptor positive breast cancer , female breast carcinoma , progesterone-receptor positive breast cancer Mayo Clinic
Completed
No outcome recorded
Phase 1
NCT02259010 Oct 2014 → Mar 2015 lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT02214147 Aug 2014 → Apr 2016 cancer , lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT01639911 Aug 2013 → Jul 2016 breast cancer , central nervous system cancer , digestive system cancer , head and neck neoplasm +2 University of Illinois at Chicago
Completed
No outcome recorded
Phase 1
NCT01924260 Aug 2013 → Feb 2017 pancreatic acinar cell carcinoma , pancreatic ductal adenocarcinoma Edward Kim
Completed
No outcome recorded
Phase 1
NCT01923337 Aug 2013 → Oct 2016 colon mucinous adenocarcinoma , colon signet ring cell adenocarcinoma , rectal signet ring cell adenocarcinoma , rectum mucinous adenocarcinoma University of California, Davis
Completed
No outcome recorded
Phase 1
NCT01613261 Aug 2013 → Sep 2015 neoplasm Millennium Pharmaceuticals, Inc.
Withdrawn
No outcome recorded
Phase 1
NCT01897012 Jul 2013 → Oct 2018 Burkitt lymphoma , Hodgkins lymphoma , diffuse large B-cell lymphoma , follicular lymphoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01898078 Jul 2013 → Mar 2014 cancer , lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT01844583 Jun 2013 → Aug 2014 cancer , lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT01677559 May 2013 → Sep 2014 adenocarcinoma , pancreatic neoplasm Washington University School of Medicine
Completed
No outcome recorded
Phase 1
NCT01779843 Apr 2013 → Nov 2015 acute myeloid leukemia Massachusetts General Hospital
Completed
No outcome recorded
Phase 1
NCT01714947 Jan → Apr 2013 cancer , lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT01695941 Aug 2012 → May 2018 overdue mantle cell lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01567709 Apr 2012 → Mar 2018 B-cell adult acute lymphocytic leukemia , Burkitt lymphoma , Hodgkins lymphoma , MALT lymphoma +19 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01512758 Feb 2012 → Oct 2013 cancer , lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT01540682 Feb 2012 → Nov 2015 head and neck squamous cell carcinoma Abramson Cancer Center at Penn Medicine
Completed
No outcome recorded
Phase 1
NCT01094288 Aug 2010 → Feb 2014 prostate adenocarcinoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT00962091 Sep 2009 → Dec 2011 cancer Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT02444884 Sep 2008 → Dec 2011 childhood malignant neoplasm , neuroblastoma Children's Oncology Group
Completed
No outcome recorded
Phase 1
NCT00697346 Jul 2008 → Oct 2016 Waldenstrom macroglobulinemia , anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , chronic lymphocytic leukemia/small lymphocytic lymphoma +7 Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT00651664 Oct 2007 → Sep 2010 cancer Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1
NCT00500903 May 2007 → Aug 2010 cancer Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Show 24 more trials Phase 1/2 7 trials
Phase 1/2
NCT04555837 Sep 2020 → Apr 2025 head and neck squamous cell carcinoma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT01848067 Aug 2013 → Mar 2015 hormone-resistant prostate carcinoma , prostate adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 1/2
NCT01601535 May 2012 → Jul 2018 neuroblastoma New Approaches to Neuroblastoma Therapy Consortium
Completed
No outcome recorded
Phase 1/2
NCT01471964 Oct 2011 → Feb 2017 non-small cell lung carcinoma Fox Chase Cancer Center
Terminated
No outcome recorded
Phase 1/2
NCT01397825 Aug 2011 → Feb 2015 Burkitt lymphoma , diffuse large B-cell lymphoma , mantle cell lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1/2
NCT01045421 Feb 2010 → May 2013 breast cancer , gastroesophageal adenocarcinoma , head and neck squamous cell carcinoma , non-small cell lung carcinoma +1 Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 1/2
NCT01034553 Feb 2010 → Sep 2014 plasma cell myeloma Mayo Clinic
Completed
No outcome recorded
Phase 2 22 trials
Phase 2
NCT07465757 Sep 2026 → Mar 2028 expected small cell lung carcinoma Puma Biotechnology, Inc.
Not yet recruiting
No outcome recorded
Phase 2
NCT07706179 Aug 2026 → Aug 2028 expected hormone receptor-positive breast cancer University of Wisconsin, Madison
Not yet recruiting
No outcome recorded
Phase 2
NCT06369285 Nov 2024 → Jun 2027 expected hormone receptor-positive breast cancer Puma Biotechnology, Inc.
Recruiting
No outcome recorded
Phase 2
NCT06095505 Feb 2024 → Oct 2027 expected small cell lung carcinoma Puma Biotechnology, Inc.
Recruiting
No outcome recorded
Phase 2
NCT02860000 Jul 2017 → Jan 2022 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma , invasive breast carcinoma Mayo Clinic
Completed
No outcome recorded
Phase 2
NCT02560025 Dec 2015 → Oct 2017 acute myeloid leukemia Massachusetts General Hospital
Completed
No outcome recorded
Phase 2
NCT02293005 May 2015 → Jul 2021 lung cancer , mesothelioma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT02187991 Feb 2015 → Apr 2024 breast carcinoma US Oncology Research
Completed
No outcome recorded
Phase 2
NCT02109328 Aug 2014 → Jul 2015 transitional cell carcinoma , urinary bladder cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Completed
No outcome recorded
Phase 2
NCT02114229 May 2014 → Sep 2025 overdue atypical teratoid rhabdoid tumor St. Jude Children's Research Hospital
Active not recruiting
No outcome recorded
Phase 2
NCT02038647 May 2014 → Jan 2016 small cell lung carcinoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 2
NCT01812005 May 2013 → Oct 2015 Burkitt lymphoma , MALT lymphoma , Waldenstrom macroglobulinemia , diffuse large B-cell lymphoma +3 Ohio State University Comprehensive Cancer Center
Terminated
No outcome recorded
Phase 2
NCT01799278 Feb 2013 → Jul 2016 prostate small cell carcinoma Weill Medical College of Cornell University
Completed
No outcome recorded
Phase 2
NCT01653028 Aug 2012 → Aug 2015 leiomyosarcoma , liposarcoma , malignant peripheral nerve sheath tumor , myxofibrosarcoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01637961 Aug 2012 → Aug 2014 leiomyosarcoma of the corpus uteri National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01316692 Oct 2011 → Nov 2014 metastatic melanoma Vanderbilt-Ingram Cancer Center
Terminated
No outcome recorded
Phase 2
NCT01466881 Oct 2011 → Dec 2014 adult T-cell leukemia/lymphoma , anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , extranodal nasal NK/T cell lymphoma +1 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01154816 Feb 2011 → Dec 2015 Ewing sarcoma/peripheral primitive neuroectodermal tumor , childhood acute lymphoblastic leukemia , childhood acute myeloid leukemia , childhood kidney neoplasm +5 Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT01091428 Apr 2010 → Aug 2014 breast carcinoma , fallopian tube cancer , ovarian carcinoma , peritoneum cancer Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 2
NCT00853307 Mar → Nov 2009 ovarian carcinoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 2
NCT00807495 Feb 2009 → Jan 2011 Burkitt lymphoma , T-cell non-Hodgkin lymphoma , diffuse large B-cell lymphoma , mantle cell lymphoma Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase 2
NCT00830518 Feb 2009 → Feb 2010 acute myeloid leukemia , myelodysplastic syndrome Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Show 12 more trials Phase 3 1 trial
Phase 3
NCT01482962 Jun 2012 → Jun 2015 peripheral T-cell lymphoma, not otherwise specified Millennium Pharmaceuticals, Inc.
Completed
No outcome recorded
Phase not applicable 1 trial
— NCT02530619 Oct 2015 → May 2018 acute megakaryoblastic leukemia , myelofibrosis , primary myelofibrosis Northwestern University
Unknown
No outcome recorded